Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Genome Biology
|
January 20, 2011
Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility
David A Quigley, Minh D To, Il Jin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2022
Reply to C. Marchetti et al
Bradley J Monk, Keiichi Fujiwara, David M O'Malley, et al.
Ebiomedicine
|
February 21, 2023
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10
Olivier Colomban, Elizabeth M Swisher, Rebecca Kristeleit, et al.
JCO Precision Oncology
|
February 9, 2022
Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes
Timothy A Yap, Erika Hamilton, Todd Bauer, et al.
Developmental Biology
|
September 5, 2006
The Grainyhead-like epithelial transactivator Get-1/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4
Zhengquan Yu, Kevin K Lin, Ambica Bhandari, et al.
Developmental Biology
|
November 10, 2007
Co-factors of LIM domains (Clims/Ldb/Nli) regulate corneal homeostasis and maintenance of hair follicle stem cells
Xiaoman Xu, Jaana Mannik, Elena Kudryavtseva, et al.
Cell Reports
|
April 19, 2018
A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance
Hsien-Ming Hu, Xin Zhao, Swati Kaushik, et al.
Sleep Health
|
November 16, 2023
Effects of sleep on breakfast behaviors in recently unemployed adults
Leah C Callovini, Darlynn M Rojo-Wissar, Candace Mayer, et al.
JCO Precision Oncology
|
July 28, 2018
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation
Rachna T Shroff, Andrew Hendifar, Robert R McWilliams, et al.
British Journal of Cancer
|
July 6, 2024
PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers
Rebecca Kristeleit, Alexandra Leary, Ana Oaknin, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Genome Biology
|
January 20, 2011
Network analysis of skin tumor progression identifies a rewired genetic architecture affecting inflammation and tumor susceptibility
David A Quigley, Minh D To, Il Jin Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2022
Reply to C. Marchetti et al
Bradley J Monk, Keiichi Fujiwara, David M O'Malley, et al.
Ebiomedicine
|
February 21, 2023
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10
Olivier Colomban, Elizabeth M Swisher, Rebecca Kristeleit, et al.
JCO Precision Oncology
|
February 9, 2022
Phase Ib SEASTAR Study: Combining Rucaparib and Sacituzumab Govitecan in Patients With Cancer With or Without Mutations in Homologous Recombination Repair Genes
Timothy A Yap, Erika Hamilton, Todd Bauer, et al.
Developmental Biology
|
September 5, 2006
The Grainyhead-like epithelial transactivator Get-1/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4
Zhengquan Yu, Kevin K Lin, Ambica Bhandari, et al.
Developmental Biology
|
November 10, 2007
Co-factors of LIM domains (Clims/Ldb/Nli) regulate corneal homeostasis and maintenance of hair follicle stem cells
Xiaoman Xu, Jaana Mannik, Elena Kudryavtseva, et al.
Cell Reports
|
April 19, 2018
A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance
Hsien-Ming Hu, Xin Zhao, Swati Kaushik, et al.
Sleep Health
|
November 16, 2023
Effects of sleep on breakfast behaviors in recently unemployed adults
Leah C Callovini, Darlynn M Rojo-Wissar, Candace Mayer, et al.
JCO Precision Oncology
|
July 28, 2018
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious <i>BRCA</i> Mutation
Rachna T Shroff, Andrew Hendifar, Robert R McWilliams, et al.
British Journal of Cancer
|
July 6, 2024
PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers
Rebecca Kristeleit, Alexandra Leary, Ana Oaknin, et al.
Page
of 6